Prothena Corp Public (PRTA) Other Non-Current Assets (2013 - 2026)

Prothena Corp Public's (PRTA) quarterly Other Non-Current Assets came in at $482000.0 in Q1 2026, down 43.95% year-on-year from $860000.0 in Q1 2025, and down 43.95% quarter-over-quarter from $860000.0 in Q4 2025.

Prothena Corp Public (PRTA) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Prothena Corp Public's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $482000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 43.95% year-over-year to $482000.0 in Q1 2026; TTM through Mar 2026 was $482000.0, a 43.95% decrease from a year earlier, with the FY2025 full-year figure at $860000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets declined to $482000.0 in Q1 2026 per PRTA's latest filing, from $860000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.2 million in Q4 2022 and bottomed at $482000.0 in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $860000.0 (2023), against an average of $1.1 million.
  • Across the five-year window, Other Non-Current Assets jumped 63.61% in 2022 and plunged 61.12% in 2023, its largest moves.
  • Year by year, Other Non-Current Assets stood at $2.2 million in 2022, then plunged by 61.12% to $860000.0 in 2023, then changed by 0.0% to $860000.0 in 2024, then changed by 0.0% to $860000.0 in 2025, then plunged by 43.95% to $482000.0 in 2026.
  • Per Business Quant, the three latest PRTA Other Non-Current Assets figures stand at $482000.0 (Q1 2026), $860000.0 (Q4 2025), and $860000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 482,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 482,000.00
Dec 31, 2025 860,000.00
Sep 30, 2025 860,000.00
Jun 30, 2025 860,000.00
Mar 31, 2025 860,000.00
Dec 31, 2024 860,000.00
Sep 30, 2024 860,000.00
Jun 30, 2024 860,000.00
Mar 31, 2024 860,000.00
Dec 31, 2023 860,000.00
Sep 30, 2023 860,000.00
Jun 30, 2023 860,000.00
Mar 31, 2023 2.21 Mn
Dec 31, 2022 2.21 Mn
Sep 30, 2022 1.35 Mn
Jun 30, 2022 1.35 Mn
Mar 31, 2022 1.35 Mn
Dec 31, 2021 1.35 Mn
Sep 30, 2021 1.35 Mn
Jun 30, 2021 1.35 Mn